Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on March 18, 2025
The UAE Strengthens Its Position as a Global Maritime Hub and Takes Action on Decarbonisation
EIN Presswire
·
March 18, 2025
The UAE strengthens its position as a global maritime hub, advancing sustainability, LNG bunkering, leadership programmes, and strategic policy initiatives. DUBAI, UNITED ARAB EMIRATES, March 18, 2025 /EINPresswire.com/ -- Emirates Shipping Association …
New Vulnerability in GitHub Copilot and Cursor: How Hackers Can Weaponize Code Agents Through Compromised Rule Files
GlobeNewswire
·
March 18, 2025
TEL AVIV, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Pillar Security, a pioneering company in AI security, discovered a significant vulnerability affecting GitHub Copilot and Cursor - the world's leading AI-powered code editors. This new attack vector, …
Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk
GlobeNewswire
·
March 18, 2025
First US Phase 3 study of Photodynamic Therapy (PDT) to include neck, trunk and extremities Protocol involves one or two PDT treatments using 1-3 tubes of Ameluz® or vehicle gel over a surface area of up to 240 cm2 Treatment phase expected to be complete …
ZOOZ Power Enhances Global Strategy with New Energy Storage Solutions, Advanced Energy Management System and Expended Sales Team
GlobeNewswire
·
March 18, 2025
Tel-Aviv, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- ZOOZ Power (Nasdaq and TASE: ZOOZ), a leading provider of flywheel-based power boosters and energy management systems for enabling ultra-fast EV charging solutions, announced today the enhancement of its …
GRI Bio Participates in a Virtual Investor CEO Connect Segment
GlobeNewswire
·
March 18, 2025
Access the CEO Connect segment here LA JOLLA, CA, March 18, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the …
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI
GlobeNewswire
·
March 18, 2025
SAN MATEO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has entered into a non-binding letter of intent (“LOI”) with Global Digital Holdings Inc., conducting business as QumulusAI, a privately-held, …
CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025
GlobeNewswire
·
March 18, 2025
BERKELEY HEIGHTS, N.J., March 18, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will …
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
GlobeNewswire
·
March 18, 2025
HANOVER, Md., March 18, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, …
Can-Fite: FDA Approved Compassionate Use Treatment with Namodenoson in a Pancreatic Cancer Patient
GlobeNewswire
·
March 18, 2025
Ramat Gan, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …
REE Automotive Announces Pricing of $27 Million Registered Direct Offering of Ordinary Shares
GlobeNewswire
·
March 18, 2025
TEL AVIV, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- REE Automotive Ltd. (Nasdaq: REE) (the “Company”), an automotive technology company and provider of full by-wire electric trucks and platforms, today announced that it has entered into securities …
Foresight Announces the Integration of NVIDIA Jetson Orin into its 3D Perception Systems
GlobeNewswire
·
March 18, 2025
Foresight to equip autonomous drones and unmanned aerial vehicles with NVIDIA Jetson Orin platform for enhanced real-time perception, obstacle detection, and energy efficiency across diverse applications NESS ZIONA, Israel, March 18, 2025 (GLOBE NEWSWIRE) …
Ashvattha Therapeutics Accelerates Clinical Development Strategy with Leadership Appointment of Six Leading Retinal Specialists to Clinical Advisory Board
GlobeNewswire
·
March 18, 2025
REDWOOD CITY, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in …
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
GlobeNewswire
·
March 18, 2025
With decades of experience in pharmaceutical development and extensive genetic medicine expertise, Doug E. Williams, Ph.D., and Murray Stewart, DM FRCP, will provide strategic guidance for CAMP4’s multiple drug development efforts CAMBRIDGE, Mass., March …
PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results
GlobeNewswire
·
March 18, 2025
PRINCETON, N.J., March 18, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025
GlobeNewswire
·
March 18, 2025
CAMBRIDGE, Mass., March 18, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) …
VVC Appoints New President & Grants Options
GlobeNewswire
·
March 18, 2025
TORONTO, March 18, 2025 (GLOBE NEWSWIRE) -- VVC Exploration Corporation, dba VVC Resources, (“VVC”), (TSX-V:VVC and OTCQC:VVCVF) announces the following: Appointment of Officers The Directors appointed Mr. Bill Kerrigan as President and Chief Operating …
REE Automotive Signs MOU for Software-Defined Technology with One of The Leading Technology Companies, Paving the Way Toward Multi-Year, Large-Volume Autonomous Vehicles Framework Agreement
GlobeNewswire
·
March 18, 2025
REE is intended to be the exclusive provider of software-defined vehicle technology to this leading tech company in multiple global markets Definitive long-term collaboration agreement expected in 2025, leveraging REE's P7 platform to deliver thousands of …
Avicanna To Hold Full Year 2024 Earnings Conference Call
GlobeNewswire
·
March 18, 2025
TORONTO, March 18, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …
Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients
GlobeNewswire
·
March 18, 2025
Study represents the first clinical application of CMND-100, the Company’s proprietary drug platform Vancouver, Canada, March 18, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage …
Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 18, 2025
- Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin (“MICVO,” formerly PYX-201), including a confirmed 50% objective response rate by RECIST 1.1 in recurrent and metastatic head and neck squamous cell …